8-A12G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-A/A

Amendment No. 2 to

Form 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

NMT Medical, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	95-4090463
(State of Incorporation or Organization)	(I.R.S. Employer Identification No.)
27 Wormwood Street Boston, Massachusetts	02210-1625
(Address of Principal Executive Offices)	(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class to be so registered	Name of each exchange on which each class to be so registered
Common Stock (and associated Series A Junior Participating Preferred Stock purchase rights), $.001 par value	NASDAQ Global Market

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.   x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.  ¨

Securities Act registration statement file number to which this form relates (if applicable): Not applicable

Securities to be registered pursuant to Section 12(g) of the Act: None

Amendment No. 2 to Form 8-A

The undersigned Registrant hereby amends the following Items, exhibits or other portions of its Registration Statement on Form 8-A dated November 29, 2004, as amended by Amendment No. 1 dated December 14, 2006 as set forth in the pages attached hereto.

Item 1. Description of Registrant’s Securities to be Registered.

Item 1 of the Form 8-A dated June 7, 1999, as amended by Amendment No. 1 dated November 15, 2006 (the “Form 8-A”) filed by NMT Medical, Inc. (the “Company”) is hereby amended as follows:

On June 8, 2009, the Company entered into Amendment No. 2 (the “Amendment”) to the Rights Agreement dated as of June 7, 1999, and amended on December 14, 2006 (as amended, the “Rights Agreement”), between the Company and American Stock Transfer & Trust Company, the Rights Agent. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Rights Agreement.

Pursuant to the Amendment, the definition of “Final Expiration Date” in the Rights Agreement shall change from June 9, 2009 to June 9, 2019.

The foregoing summary of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, which is attached as Exhibit 3 hereto and incorporated herein by reference.

Item 2. Exhibits.

Item 2 of the Form 8-A is hereby amended by adding the following exhibit attached hereto:

Exhibit No.	Description
3	Amendment No. 2, dated as of June 8, 2009, to Rights Agreement, dated as of June 17, 1999, between NMT Medical, Inc. and American Stock Transfer & Trust Company, as amended on December 14, 2006.

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Amendment No. 2 to registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: June 9, 2009	NMT MEDICAL, INC.
	By:	/S/    RICHARD E. DAVIS
		Richard E. Davis Chief Operating Officer

EXHIBIT INDEX

Exhibit No.	Description
3	Amendment No. 2, dated as of June 8, 2009, to Rights Agreement, dated as of June 17, 1999, between NMT Medical, Inc. and American Stock Transfer & Trust Company, as amended on December 14, 2006.

EX-3

Exhibit 3

AMENDMENT NO. 2 TO

RIGHTS AGREEMENT

This AMENDMENT, dated as of June 8, 2009 (the “Amendment”), amends the Rights Agreement, dated as of June 7, 1999 (as amended, the “Rights Agreement”), between NMT Medical, Inc. (formerly Nitinol Medical Technologies, Inc.), a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, a New York company, as Rights Agent (the “Rights Agent”), as amended on December 14, 2006.

WHEREAS, under Section 27 of the Rights Agreement, the Company may from time to time supplement or amend the Rights Agreement without the approval of any holders of the Rights in order to, among other thing, make any provisions with respect to the Rights that the Company may deem necessary or desirable, any such supplement or amendment to be evidenced by a writing signed by the Company and the Rights Agent; and

WHEREAS, the Company has determined, and has so directed the Rights Agent, to amend the Rights Agreement as set forth herein pursuant to Section 27 of the Rights Agreement.

NOW, THEREFORE, in consideration of the foregoing and the mutual agreements set forth herein, and intending to be legally bound, the parties hereto agree as follows:

1. Section 1(o) of the Rights Agreement is hereby deleted in its entirety and replaced with the following language:

“‘Final Expiration Date’ shall mean the close of business on June 9, 2019.”

2. This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of the State of Delaware applicable to contracts to be made and performed entirely within the State of Delaware.

3. All acts and things necessary to make this Amendment a valid agreement, enforceable according to its terms, have been done and performed, and the execution and delivery of this Amendment by the Company and the Rights Agent have been in all respects duly authorized by the Company and the Rights Agent.

4. This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

5. In all respects not inconsistent with the terms and provisions of this Amendment, the Rights Agreement is hereby ratified, adopted, approved and confirmed. In executing and delivering this Amendment, the Rights Agent shall be entitled to all the privileges and immunities afforded to the Rights Agent under the terms and conditions of the Rights Agreement.

6. Capitalized terms used herein and not otherwise defined shall have the meanings given to such terms in the Rights Agreement.

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and attested, as of the date first set forth above.

Attest:		NMT MEDICAL, INC.
By:	/S/    FRANCIS J. MARTIN	By:	/S/    RICHARD E. DAVIS
	Name:  Francis J. Martin Title:    President and CEO		Name:  Richard E. Davis Title:    Chief Operating Officer
Attest:		AMERICAN STOCK TRANSFER & TRUST COMPANY
By:	/S/    ANTHONY J. FOTI	By:	/S/    JOSEPH F. WOLF
	Name:  Anthony J. Foti Title:    Account Administrator		Name:  Joseph F. Wolf Title:    Vice President